Occupational exposures to illicit drugs in forensic science divisions, urine analysis
ID: 75D30123P17756Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Colleges, Universities, and Professional Schools (611310)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/ac4ba21bb5da4fe0a8843eb81ab232b7/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract to the University of California, San Francisco (UCSF) for urine analysis services related to occupational exposures to illicit drugs in forensic science divisions. The contract aims to analyze urine samples for substances such as cocaine, fentanyl, heroin, and methamphetamine, utilizing UCSF's specialized liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology, which provides the lowest achievable detection limits for these drugs. This procurement is critical for addressing significant gaps in knowledge regarding the health risks faced by forensic science workers who may be exposed to these hazardous substances, with the contract period set from March 1, 2024, to February 28, 2027. Interested parties may submit their interest and capability to respond to this requirement by emailing Laurie Presley at xnp0@cdc.gov by 1:00 PM Eastern Time on November 15, 2024.

    Point(s) of Contact
    Laurie Presley
    xnp0@cdc.gov
    Files
    Title
    Posted
    D2d. SSJ_23P17756_MOD 00002_COSigned_Redacted.pdf
    The document outlines a justification for a sole source procurement by the National Institute for Occupational Safety and Health (NIOSH) for urine analysis services provided by the University of California, San Francisco (UCSF). The procurement is categorized under a sole source acquisition due to UCSF's unique capability in employing liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect low-level illicit drugs, including cocaine and fentanyl, which meets specific detection requirements not available elsewhere. The justification includes the need for increased urine sample analyses over the next option years. The document complies with Federal Acquisition Regulation (FAR) guidelines accommodating situations where only one vendor can fulfill the requirements efficiently and with the necessary quality. It also emphasizes the urgency and specialized nature of the services, presenting UCSF as the only vendor capable of delivering the analyses within the required timeframe. The program office conducted market research, ruling out other potential vendors, confirming UCSF's proprietary technology as essential for their operational needs. Both the program and contracting offices certified the justification's accuracy and necessity.
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves a range of tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA) or 510(k) approval, and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Proposals are due by December 2, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. Interested parties can contact Shayna Connery at xvj9@cdc.gov or (404) 498-0715 for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million anticipated over the contract period from September 1, 2025, to May 14, 2031. Interested parties should direct inquiries to Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov, and submit proposals by the deadline of December 3, 2024.
    Hologic Equipment Maintenance Service Contract
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to issue a sole source contract for a one-year Hologic Equipment Maintenance Service Agreement, with the possibility of extensions, to ensure the proper functioning of critical laboratory equipment used in HIV research. The contract will require the contractor to provide preventive maintenance, repairs, and necessary parts exclusively from Hologic, Inc., the sole manufacturer of the Panther systems essential for HIV testing, emphasizing the urgency and proprietary nature of the services needed. This procurement is vital for maintaining high standards in laboratory operations that support public health outcomes, with a response deadline for interested parties set for November 19, 2024, at 1:00 P.M. ET. Interested vendors must contact Stephanie Reid at qsi5@cdc.gov and be registered in the System for Award Management (SAM) to participate.
    Notice of Intent to Award Sole Source
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract to Metro Health for access to the Epic Cosmos electronic health record dataset. This dataset, which encompasses electronic health records from over 240 million patients across all 50 states, is crucial for assessing real-world effectiveness questions, particularly regarding rare health outcomes, due to its real-time updates and comprehensive features. Interested parties may express their interest and capability to respond to this requirement within fifteen days of this notice, with all communications directed to contract specialist Peter Loree at zus0@cdc.gov. This procurement is not open for competitive quotations, and the government retains discretion over whether to pursue competitive procurement based on the responses received.
    Service/Maintenance Agreement for the Agilent instrumentation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a service and maintenance agreement for Agilent instrumentation utilized at the National Center for Advancing Translational Sciences (NCATS). This procurement aims to ensure the operational integrity and performance of Agilent Liquid Chromatography/Mass Spectrometry (LCMS) systems, which are critical for various research applications, including high-throughput mass spectrometry analysis. The contract, valued at an estimated amount not exceeding $7.5 million, is intended to be awarded on a sole-source basis to Agilent Technologies Inc., as they are the only authorized provider capable of maintaining these systems without voiding existing warranties. Interested parties must submit their capabilities and proposals by November 22, 2024, to Patricia da Silva at patricia.dasilva@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    R--FBO Foe FASD Coordinator
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to serve as the FASD Coordinator for a project focused on analyzing a master dataset from 16 studies related to Fetal Alcohol Spectrum Disorder (FASD). The contractor will be responsible for data cleaning, integration, hypothesis testing, and statistical analysis, under the supervision of Dr. Julie Kable from Emory University, and will also provide training to NIAAA fellows on data analysis methods. This project is critical for understanding the impacts of prenatal alcohol exposure, which often leads to undiagnosed physical and cognitive impairments in affected individuals. Interested bidders must register with SAM and submit their technical and price quotations by November 26, 2024, for the contract period running from December 1, 2024, to November 30, 2025. For further inquiries, contact Michael L. Falzone at falzoneml@nih.gov or +1 301 827 1873.
    The Navy Medical Readiness Logistics Command Detachment Fort Detrick has a requirement for the Drug Demand Reduction Program, for the initial (screen) immunoassay for the detection of 6-Acetylmorphine Immunoassay Reagent Kits in urine > 10 ng/mL.
    Active
    Dept Of Defense
    The Department of Defense, specifically the Navy Medical Readiness Logistics Command Detachment Fort Detrick, is seeking proposals for the procurement of FDA-approved Immunoassay Reagent Kits designed for the detection of 6-acetylmorphine (6AM) in urine samples. The contract requires vendors to provide reagent kits compatible with Beckman Coulter AU5800 series analyzers, capable of conducting up to 500,000 tests per month over a five-year period, while adhering to stringent FDA and quality management documentation standards. This procurement is critical for the Drug Demand Reduction Program, ensuring accurate and reliable drug testing within the Department of Defense. Interested vendors must submit technical documentation by October 25, 2024, with final quotes due by November 22, 2024. For further inquiries, contact James Berghaier at 215-697-2022 or via email at james.berghaier@navy.mil.
    6640--VA Central California Health Care System Chemistry & Immunoassay CPRR Equipment and Tests
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide clinical laboratory analyzer equipment for Chemistry and Immunoassay testing on a Cost Per Reportable Result (CPRR) basis for the VA Central California Health Care System. This procurement involves a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which will span from April 2025 to September 2029, and includes specific ordering periods for various laboratory tests and equipment. The initiative is crucial for enhancing diagnostic capabilities and ensuring high-quality healthcare services for veterans, with a focus on automation, reliability, and compliance with federal regulations. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov or David J. Alvarez at david.alvarez4@va.gov for further details regarding the solicitation, identified as 36C26125Q0065.